Background: The pharmacology of traumatic memory extinction has not been fully characterized despite its potential as a therapeutic target for established, acquired anxiety disorders, including post-traumatic stress disorder (PTSD). Here we examine the role of endogenous glucocorticoids in traumatic memory extinction. Methods: Male C57BL/6J mice were injected with corticosterone (10 mg/kg, i.p.) or metyrapone (50 mg/ kg, s.c.) during re-activation of a contextual fear memory, and compared to vehicle groups (N = 10-12 per group). To ensure that metyrapone was blocking corticosterone synthesis, we measured corticosterone levels following re-activation of a fear memory in metyrapone-and vehicle-treated animals. Results: Corticosterone administration following extinction trials caused a long-lasting inhibition of the original fear memory trace. In contrast, blockade of corticosteroid synthesis with metyrapone prior to extinction trials enhanced retrieval and prevented extinction of context-dependent fear responses in mice. Further behavioral analysis suggested that the metyrapone enhancement of retrieval and prevention of extinction were not due to non-specific alterations in locomotor or anxiety-like behavior. In addition, the inhibition of extinction by metyrapone was rescued by exogenous administration of corticosterone following extinction trials. Finally, we confirmed that the rise in corticosterone during re-activation of a contextual fear memory was blocked by metyrapone. Conclusions: We demonstrate that extinction of a classical contextual fear memory is dependent on endogenous glucocorticoid synthesis during re-activation of a fear memory. Our data suggest that decreased glucocorticoids during fear memory re-activation may contribute to the inability to extinguish a fear memory, thus contributing to one of the core symptoms of PTSD.
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Introduction
The formation of a fear memory following a traumatic event is an important mechanism for the subsequent development of anxiety disorders, such as post-traumatic stress disorder (PTSD) or phobias (LeDoux, 2003; Mineka & Oehlberg, 2008; Phelps & LeDoux, 2005; Pitman, 1989; Yehuda & LeDoux, 2007) . For most people, intrusive fear memory retrieval extinguishes or declines over time. Unfortunately, in people that develop a chronic anxiety disorder (like PTSD) the fear memory does not extinguish and thus, can remain easily recalled by a trauma-associated cue (de Quervain, Aerni, Schelling, & Roozendaal, 2009) . Indeed, the inability to extinguish fear responses is a common feature for most anxiety disorders, and PTSD in particular (Blechert, Michael, Grossman, Lajtman, & Wilhelm, 2007; Michael, Blechert, Vriends, Margraf, & Wilhelm, 2007; Yang, Chao, & Lu, 2006) . Thus, it is necessary to identify factors that modulate the progressive extinction of fear memories.
There is growing evidence from both human and rodent studies that glucocorticoids released from the adrenal cortex play a key role in learning and memory. Glucocorticoids (corticosterone in animals and cortisol in humans) can dose-dependently enhance the consolidation of new fear memoires (Abercrombie, Kalin, Thurow, Rosenkranz, & Davidson, 2003; McGaugh & Roozendaal, 2002; Okuda, Roozendaal, & McGaugh, 2004; Roozendaal, 2002; Sandi & Rose, 1994) . Similarly, pharmacological blockade of corticosterone or cortisol synthesis with metyrapone impairs memory consolidation in both animals and humans (Maheu, Joober, Beaulieu, & Lupien, 2004; Roozendaal, Bohus, & McGaugh, 1996) . Evidence from both animals and humans suggests that glucocorticoids can act in the amygdala to modulate the memory
